Ameriprise Financial Inc Harrow Health, Inc. Transaction History

Ameriprise Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $11,876 - $16,894	-1,277 Reduced 2.16%	57,750 $764,000
Q4 2023 Feb 14, 2024	SELL	$8.1 - $16.36 $58,546 - $118,250	-7,228 Reduced 10.91%	59,027 $661,000
Q3 2023 Nov 14, 2023	SELL	$14.03 - $22.08 $8,277 - $13,027	-590 Reduced 0.88%	66,255 $952,000
Q2 2023 Aug 14, 2023	SELL	$17.37 - $28.08 $537,497 - $868,907	-30,944 Reduced 31.64%	66,845 $1.27 Million
Q1 2023 May 15, 2023	SELL	$13.84 - $21.46 $353,044 - $547,423	-25,509 Reduced 20.69%	97,789 $2.07 Million
Q4 2022 Feb 14, 2023	SELL	$10.28 - $14.78 $14,864 - $21,371	-1,446 Reduced 1.16%	123,298 $1.82 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $127,497 - $482,821	19,406 Added 18.42%	124,744 $1.51 Million
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $605,693 - $815,316	105,338 New	105,338 $767,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.